Key Takeaways
- NOC shares declined approximately 2% following Q1 results that surpassed expectations with EPS of $6.14 versus the $6.03 estimate and revenue reaching $9.88 billion, representing 4.4% year-over-year growth
- Aeronautics segment revenue surged 17%, fueled by B-21 Raider transitioning into low-rate initial production phase
- Air Force approval granted for 25% expansion in annual B-21 production capacity
- Total backlog reaches $96 billion, with management planning $2.5 billion in B-21 facility investments extending through 2029
- Analyst consensus stands at Moderate Buy with average price target of $743.33, suggesting approximately 29% potential upside
Northrop Grumman (NOC) delivered first-quarter results on April 21 that exceeded Wall Street forecasts, yet shares retreated roughly 2% in response. The market’s reaction appears counterintuitive at first glance, though deeper examination reveals specific concerns driving investor sentiment.
Northrop Grumman Corporation, NOC
The defense contractor posted adjusted earnings per share of $6.14, surpassing analyst expectations of $6.03. Quarterly revenue totaled $9.88 billion, marking a 4.4% increase compared to the prior-year period and exceeding the $9.75 billion consensus forecast. By conventional measures, these results represent solid performance.
Market participants appear focused on management’s decision to raise 2026 capital expenditure guidance by $200 million, combined with a $71 million unfavorable adjustment in the Space segment stemming from the GEM 63XL program. While neither development represents a material setback, both factors captured investor attention.
The Aeronautics division emerged as the quarter’s strongest performer. Revenue climbed 17%, propelled by the B-21 Raider stealth bomber advancing into low-rate initial production. Segment margins improved to 9.3%, benefiting partly from the absence of loss charges that impacted results earlier in 2025.
A significant development came through Air Force approval to increase annual B-21 production capacity by 25%. This decision reflects tangible demand rather than speculative planning.
Defense Systems recorded 5% sales growth, with the Sentinel intercontinental ballistic missile program continuing its development trajectory. Mission Systems posted flat revenue comparisons, though operating income jumped 20% on favorable contract adjustments.
B-21 Production Expansion Provides Forward Revenue Clarity
Company leadership indicated plans to deploy $2.5 billion in internal capital toward B-21 production facilities through 2029. Over the past two years, Northrop has inaugurated more than 20 new facilities, demonstrating its commitment to scaling manufacturing capabilities.
The order backlog stands at $96 billion, representing approximately two to three years of secured future revenue. Management maintained fiscal 2026 EPS guidance at $27.40–$27.90 following the quarterly report.
Shares currently trade around 21 times the 2026 consensus EPS estimate of $27.93. The stock’s 52-week range spans from $453.01 to $774.00, with Monday’s opening price of $575.57 falling below both the 50-day moving average of $699.43 and the 200-day average of $638.36.
Wall Street Maintains Constructive Stance
Vanguard Group expanded its NOC holdings by 1.5% during Q4, elevating its ownership stake to approximately 9.63% of outstanding shares.
Among sell-side firms, Royal Bank of Canada elevated its price target to $750 while maintaining an Outperform rating. Deutsche Bank holds a Buy rating with a $765 target. UBS adjusted its target downward from $806 to $745 while preserving its Buy recommendation. Citigroup similarly reduced its target from $807 to $742, keeping a Buy rating intact. Jefferies shifted to a Hold stance.
The Street consensus registers as Moderate Buy, derived from 10 Buy ratings and five Hold recommendations. Zero analysts currently maintain Sell ratings on NOC. The average price target of $743.33 points to roughly 29% upside potential from present trading levels.
The company announced a quarterly dividend of $2.31 per share, distributed March 11, translating to an annualized payout of $9.24 and a yield of 1.6%.
Recent insider transaction activity included Chief Accounting Officer Michael Hardesty selling 147 shares at $732.98 each on February 19.
